Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Trading Statement

27 Apr 2017 07:00

RNS Number : 4698D
Kingspan Group PLC
27 April 2017
 

Kingspan Group Plc

Trading Update

 

27 April 2017

 

Kingspan Group plc, the global leader in high performance insulation, building fabric, and solar integrated building envelopes, is issuing this Trading Update in advance of its Annual General Meeting which is being held today at 10.00am in Dublin.

Overall, Kingspan has experienced a good start to the year reflecting a combination of solid underlying markets and the acquisitions made in 2016 bedding down well. Group sales of €831.2m for the three month period to 31 March were 24% ahead of prior year (+26% pre-currency, +14% pre currency and acquisitions).

 

By market, the UK remains solid overall although is a little softer than at the turn of the year. Mainland European markets continue to show signs of recovery with decent volumes overall. The US market is a little more encouraging than conditions experienced towards the end of last year. The Middle East and Turkey regions are subdued, with Australia and its adjacent markets showing more positive signs. A feature of all markets has been ongoing raw material inflation and the associated recovery effort.

 

Insulated Panel sales revenues were up 32% (+33% pre-currency, +16% pre-currency and acquisitions). Volumes in most key end markets are positive with the key trading priority being margin. Light & Air contributed 6% to divisional sales in the quarter, on plan, and is an excellent addition to the Group's high performance product suite.

Insulation Board sales revenues were up 8% (+11% pre-currency) in the period. The Kooltherm® mix has been positive overall with raw material inflation experienced in all territories and the associated recovery underway. The Group's new Kooltherm® facility for the Australasian market was successfully commissioned in Melbourne during the period.

 

Access Floors sales revenues were up 6% (+8% pre-currency). US activity is subdued, as was the case last year. The UK is holding up well for the moment although the pipeline is indicating weakness towards the end of 2017.

 

Environmental sales revenues were up 13% (+21% pre-currency, 3% pre currency and acquisitions). Overall, the division has had a good start to the year with the Rainwater harvesting business in Australia a particular highlight.

 

Net debt at 31 March was €457m, an increase of €29m from the position at last year end reflecting, in the main, the seasonal investment in working capital. The Group's funding position is robust with €639m of committed undrawn facilities and cash balances.

 

Looking ahead, the order backlog across the Group overall points towards a solid first half for the business. The project pipeline is encouraging in most of our major markets, although trending weaker in the U.K. in recent weeks. The key trading priority is the pass through of increases in input costs, and the associated lag likely to persist in a tight supply environment into the second quarter, and perhaps beyond. As a consequence, likely sales growth in the first half is expected to outpace profit growth in the period. Overall, the Group remains well positioned given the breadth of our product and market mix, our development agenda over time, together with the ongoing advancement of our high performance technology.

 

Kingspan will issue its half-year financial report for the period ended 30 June 2017 on Friday 18 August 2017.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDQLFLDZFBBBZ
Date   Source Headline
12th Feb 20145:32 pmRNSBlocklisting Application
5th Feb 201412:48 pmRNSHolding(s) in Company
2nd Jan 20143:19 pmRNSHolding(s) in Company
2nd Jan 20147:00 amRNSBlocklisting Interim Review
2nd Jan 20147:00 amRNSTotal Voting Rights
16th Dec 201310:09 amRNSHolding(s) in Company
6th Dec 20135:43 pmRNSHolding(s) in Company
27th Nov 20135:21 pmRNSHolding(s) in Company
26th Nov 201310:51 amRNSHolding(s) in Company
22nd Nov 20137:00 amRNSInvestor & Analyst Seminar
19th Nov 201312:56 pmRNSHolding(s) in Company
14th Nov 20133:59 pmRNSHolding(s) in Company
13th Nov 20133:14 pmRNSDirector/PDMR Shareholding
11th Nov 20137:00 amRNSInterim Management Statement
7th Nov 201312:01 pmRNSHolding(s) in Company
1st Nov 201311:24 amRNSTotal Voting Rights
29th Oct 20134:53 pmRNSHolding(s) in Company
21st Oct 201310:52 amRNSDirector/PDMR Shareholding
15th Oct 20135:21 pmRNSHolding(s) in Company
1st Oct 20139:36 amRNSTotal Voting Rights
25th Sep 20131:00 pmRNSHolding(s) in Company
24th Sep 20131:06 pmRNSHolding(s) in Company
17th Sep 201310:02 amRNSDirector/PDMR Shareholding
2nd Sep 20139:47 amRNSTotal Voting Rights
19th Aug 20137:00 amRNSHalf Yearly Report
2nd Jul 20134:28 pmRNSHolding(s) in Company
1st Jul 201311:26 amRNSBlocklisting Interim Review
1st Jul 201311:23 amRNSTotal Voting Rights
14th Jun 201312:10 pmRNSHolding(s) in Company
12th Jun 20134:09 pmRNSHolding(s) in Company
4th Jun 20135:29 pmRNSDirector Declaration
4th Jun 201310:28 amRNSTotal Voting Rights
21st May 20134:44 pmRNSHolding(s) in Company
13th May 20135:40 pmRNSHolding(s) in Company
9th May 201310:56 amRNSResult of AGM
9th May 20137:00 amRNSInterim Management Statement
1st May 201312:30 pmRNSTotal Voting Rights
11th Apr 20134:07 pmRNSHolding(s) in Company
5th Apr 20137:00 amRNSAnnual Financial Report
2nd Apr 201311:26 amRNSTotal Voting Rights
27th Mar 20134:34 pmRNSDirector/PDMR Shareholding
26th Mar 20134:20 pmRNSDirector/PDMR Shareholding
7th Mar 20136:25 pmRNSHolding(s) in Company
4th Mar 20133:19 pmRNSDirector/PDMR Shareholding
1st Mar 20137:00 amRNSTotal Voting Rights
26th Feb 201311:57 amRNSDirector/PDMR Shareholding
25th Feb 20137:00 amRNSFinal Results
25th Feb 20137:00 amRNSMain Securities Market Notice
11th Feb 20135:03 pmRNSBlock Listing Application
6th Feb 20137:00 amRNSDirector Declaration - Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.